BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1077769)

  • 1. Comparative pharmacology of new specific angiotensin antagonists.
    Schoelkens BA
    Clin Sci Mol Med Suppl; 1975 Jun; 2():19s-21s. PubMed ID: 1077769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemistry and mechanism of new angiotensin UU antagonists: 8 C-phenylclycine analogues of [5-isoleucine] angiotensin].
    Wissmann H; Schoelkens B; Lindner E; Geiger R
    Hoppe Seylers Z Physiol Chem; 1974 Sep; 355(9):1083-96. PubMed ID: 4376799
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis of angiotensin II antagonists containing N- and O-methylated and other amino acid residues.
    Khosla MC; Mũnoz-Ramírez H; Hall MM; Smeby RR; Khairallah PA; Bumpus FM; Peach MJ
    J Med Chem; 1976 Feb; 19(2):244-50. PubMed ID: 2777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,8-disubstituted analogues of (Ile5) and (Val5)angiotensin II: difference in potency and specificity of angiotensin II-antagonistic activity.
    Schoelkens BA; Wissmann H; Lindner E; Geiger R
    Hoppe Seylers Z Physiol Chem; 1976 Jun; 357(6):825-38. PubMed ID: 955577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Specific antagonism between angiotensin II and several of its analogs].
    Myshliakova NV; Auna ZP; Indulen IuI; Klusha VE; Chipens GI
    Probl Endokrinol (Mosk); 1976; 22(3):85-9. PubMed ID: 935097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo studies of (1-sarcosine, 8-threonine) angiotensin II.
    Muñoz-Ramírez H; Khosla MC; Hall MM; Bumpus FM; Khairallah PA
    Res Commun Chem Pathol Pharmacol; 1976 Apr; 13(4):649-63. PubMed ID: 4864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of DuP 532, a selective and noncompetitive AT1 receptor antagonist.
    Wong PC; Hart SD; Chiu AT; Herblin WF; Carini DJ; Smith RD; Wexler RR; Timmermans PB
    J Pharmacol Exp Ther; 1991 Nov; 259(2):861-70. PubMed ID: 1941632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of angiotensin.
    Regoli D; Park WK; Rioux F
    Pharmacol Rev; 1974 Jun; 26(2):69-123. PubMed ID: 4371235
    [No Abstract]   [Full Text] [Related]  

  • 9. The pharmacological characterization of FK 739, a new angiotensin II-receptor antagonist.
    Hamada K; Nakajima Y; Nirei H; Nakajima C; Nagashima A; Sogabe K; Notsu Y; Ono T
    Jpn J Pharmacol; 1993 Nov; 63(3):335-43. PubMed ID: 8107326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the non-peptide angiotensin II receptor antagonist TCV-116 on systemic and renal hemodynamics in dogs with renal hypertension.
    Ito K; Shiomi M; Kito G
    Hypertens Res; 1995 Mar; 18(1):69-75. PubMed ID: 7584913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure response to central and peripheral injection of angiotensin II and 8-C-phenylglycine analogue of angiotensin II in rats with experimental hypertension.
    Schoelkens BA; Jung W; Steinback R
    Clin Sci Mol Med Suppl; 1976 Dec; 3():403s-406s. PubMed ID: 1071654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of angiotensin antagonists in various forms of experimental arterial hypertension.
    Ferrario CM; Bumpus FM; Masaki Z; Khosla MC; McCubbin JW
    Prog Biochem Pharmacol; 1976; 12():86-97. PubMed ID: 1019172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the angiotensin II blocker 1-Sar-8-Ala-angiotensin II on renal artery clip hypertension in the rat.
    Macdonald GJ; Boyd GW; Peart WS
    Circ Res; 1975 Nov; 37(5):640-6. PubMed ID: 1192561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new, long-lasting competitive inhibitor of angiotensin.
    Türker RK; Hall MM; Yamamoto M; Sweet CS; Bumpus FM
    Science; 1972 Sep; 177(4055):1203-5. PubMed ID: 4341570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new approach to angiotensin antagonists: methylation of the tyrosine hydroxyl in angiotensin II.
    Scanlon MN; Matsoukas JM; Franklin KJ; Moore GJ
    Life Sci; 1984 Jan; 34(4):317-21. PubMed ID: 6546405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the pressor and aldosterone-releasing effects of angiotensin II.
    Bumpus FM; Khosla MC
    Clin Sci Mol Med Suppl; 1975 Jun; 2():15s-18s. PubMed ID: 1077765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of octanoyl[8-leucyl]angiotensin II, a lipophilic angiotensin antagonist.
    Paiva AC; Nouailhetas VL; Paiva TB
    J Med Chem; 1977 Jul; 20(7):898-901. PubMed ID: 874965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of [1-sarcosine, 8-O-methylserine]angiotensin II and 1-substituted analogues of [8-threonine]angiotensin II as antagonists of angiotensin II.
    Khosla MC; Hall MM; Munoz-Ramírez H; Khairallah PA; Bumpus FM
    J Med Chem; 1977 Feb; 20(2):253-6. PubMed ID: 836496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of angiotensin II antagonists containing sarcosine in position 7.
    Moore GJ; Oudeman EM; Ko D; Nystrom DM
    J Med Chem; 1979 Sep; 22(9):1147-9. PubMed ID: 490564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ selective angiotensin antagonists: sarcosyl1-cysteinyl(S-methyl)8-angiotensin I.
    Freer RJ; Sutherland JC; Day AR
    Eur J Pharmacol; 1980 Aug; 65(4):349-54. PubMed ID: 7408944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.